drugset / Trial / NCT05060822
Phase ll Study of HEC585 in Patients With IPF
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase ll Study to evaluate the efficacy and safety of various doses of HEC585 Tablets in patients with idiopathic pulmonary fibrosis
Timeline
- Start
- 2021-06-30
- Primary completion
- 2025-07-16
- Completion
- 2026-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HEC585 | Small molecule | — | — |
| Comparator | Pirfenidone | Small molecule | — | — |